Kore Potash: A $2 Billion Mine Trapped in a £186 Million Shell

The filing that caught this article's attention is almost entirely empty. On 4 September, Shore Capital Stockbrokers disclosed to the London market that, dealing in a "client-serving capacity" in Kore Potash ordinary shares, it sold 143,169 of them at 3.475 pence each and bought none. Under Rule 8.5 of the UK Takeover Code, that form must be filed every time an exempt principal trader touches the shares. It says nothing about a bid, a price, or even who is in the room. What it does say is that Kore Potash is still sitting inside a live "possible offer" situation — and has been for ten months.

That is the whole signal. Kore Potash, a potash development company listed in London, Sydney and Johannesburg, launched a formal sale process on 4 November 2025 after receiving approaches from two parties. One suspended its interest in February, and a new party joined in June; two parties remain engaged as of the June AGM, with the Takeover Panel having granted the company a dispensation that keeps the bidders anonymous and suspends the usual 28-day "put up or shut up" deadline. No firm offer has been made, and under that dispensation there is no forced timetable for one. The daily 8.5 forms are the paper trail of a process that can, in principle, run on indefinitely.

Why a trader's daily disclosure is the visible heartbeat of a mooted takeover instead of a footnote is the question that tells you what is really going on here. Kore Potash is a tiny company owning a very large mine it cannot afford to build.

The £186 million company and the $2 billion mine

The flagship asset, the Kola potash project in the Republic of Congo, is genuinely hard to replace. It sits on 152 million tonnes of proved and probable reserves grading 32.5% potassium chloride, among the highest-grade sylvinite deposits in the world, with a dedicated mining lease, an approved environmental assessment, and a fixed-price engineering, procurement and construction contract worth $1.93 billion signed with PowerChina. The full-build cost comes to about $2.07 billion.

That number matters only when set beside the company that owns it. Kore Potash's shares are worth on the order of £186 million. The project would cost roughly nine times the entire market value of the company to build. It has no revenue and burns cash; after a $12.2 million raise last November it held about $10.6 million at the end of 2025, and its own directors' cash-flow forecast shows it running short of liquidity by early 2027 without another capital injection. On the equity balance sheet, Kola is not a value you can underwrite; it is a funding gap the company cannot close on its own.

That is precisely why the sale process exists, and why an equity holder's entire outcome depends on a counterparty. Either someone acquires the company (and the reserves, lease and contract that come with it) at a premium to the market, or construction funding arrives on terms so dilutive that first production — targeted for the first half of 2030 — belongs mostly to whoever wrote the check.

Why the discount to $1.7 billion is thinner than it looks

A value investor's first instinct is to measure the gap between the market's £186 million and the mine's own economics. The optimised feasibility study, published in February 2025, put the project's post-tax net present value at roughly $1.7 billion at a 10% discount rate, with an 18% real, ungeared internal rate of return and average annual EBITDA near $733 million. On its face that is an enormous and obvious gap — more than seven times the company's market value.

The gap is real, but it is not the sevenfold premium the headline implies, because those figures are not what the market would pay. They are generated by an assumption inside the study: a potash price of about $449 per tonne, in real terms, on a CFR Brazil basis, against a delivered cost of roughly $128 a tonne. The market's price is not the study's price. Granular muriate of potash was trading near $300 a tonne CFR Brazil when the study was released, and the broader spot benchmark has been around $387 a tonne this summer. Either way, the buyer underwriting Kola in 2026 uses a forward price deck, not the study's $449 input — and at current prices the spread to that $128 delivered cost narrows to a fraction of what the model assumed.

The break-even line inside the study puts the floor at about $271 a tonne. Today's price clears it, so Kola is not an uneconomic project. It is a project whose headline 18% return assumed a potash market that has not shown up, in an industry that faces fresh supply from Canada, Laos and recovering Russian and Belarusian producers. A bidder pays for the reserves and the fixed-price construction contract, not for the study's internal assumptions.

The gate that decides your outcome

Strip the narrative to its financial spine and only one variable governs whether current shareholders are rewarded: the price, if any, that a buyer pays, measured against today's £186 million. Everything else — the process, the dispensation, the daily 8.5 forms — is scenery.

Two things keep that variable genuinely uncertain rather than a formality. First, the dispensation removes the deadline that normally forces a bidder to commit, so the company can wait indefinitely and the market can pay an "offer premium" for months without any offer existing. Second, even the non-sale path does not rescue the equity quickly: the $2.2 billion financing package signed on a non-binding basis last year would build the mine, but on terms — senior secured project debt plus royalty-style finance — that keep most of the first decade of cash flow out of ordinary shareholders' hands.

None of this makes the stock a buy or a sell on the evidence so far. It makes it a position whose value is a sale outcome the market is pricing as probable, not a cash-flow stream you can model, and the gap between the $1.7 billion study and today's spot is exactly the width of that optimism. A reader should read each fresh 8.5 as one thing only: proof the process is still alive. The filing will never tell you the price. Only an actual offer — one the dispensation currently shields from view — will.